首页 | 本学科首页   官方微博 | 高级检索  
     


Differential resistance to platinum‐based drugs and 5‐fluorouracil in p22phox‐overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies
Authors:Pei‐Yu Chu PhD  Yu‐Jen Wu PhD  Chang‐Shen Lin PhD  Chih‐Jen Huang MD  PhD  Leong‐Perng Chan MD  Yen‐Yun Wang PhD  Shyng‐Shiou F. Yuan MD  PhD  Tzyh‐Chyuan Hour PhD  Jeff Yi‐Fu Chen PhD
Affiliation:1. Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan;2. Department of Biological Science and Technology, Meiho University, Pingtung, Taiwan;3. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;4. Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;5. Department of Otorhinolaryngology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;6. Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;7. Translational Research Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;8. Department of Obstetrics and Gynecology and Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;9. Institute of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanThese authors contributed equally to this study.;10. Department of Biotechnology, Kaohsiung Medical University, Kaohsiung, TaiwanThese authors contributed equally to this study.
Abstract:
Keywords:5‐fluorouracil  differential resistance  oral squamous cell carcinoma  p22phox  platinum‐based drugs
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号